Have any feedback? I’d love to hear you from - connect with me on LinkedIn. 📣

Natera, Angiex collaborate to evaluate Signatera blood test in AGX101 cancer drug trial monitoring
Research collaboration, oncology, antibody-drug conjugate, diagnostics, clinical trials monitoring - Read more

Roche, Simcere Zaiming partner on B cell disease T cell engager SIM0660, $75M upfront, $1.53B milestones
Licensing deal, oncology, autoimmune, antibody, milestone payments, royalties - Read more

GSK initiates Ph3 trial of (FLUm3HA.b-3NA) mRNA flu vaccine targeting hemagglutinin and neuraminidase for seasonal influenza
Vaccine, infectious disease, mRNA vaccine, influenza, hemagglutinin, neuraminidase - Read more

Novartis' Rhapsido (remibrutinib) hits Ph3 goals in relapsing multiple sclerosis with no liver safety signal
Small molecule, autoimmune, BTK inhibitor, multiple sclerosis, relapsing MS, liver safety - Read more

Amgen's Repatha (evolocumab) linked to 20% lower mortality risk in Ph3 primary cardiovascular prevention trial
Small molecule, cardiovascular, PCSK9 inhibitor, LDL cholesterol, primary prevention, evolocumab - Read more

Cell and Gene Live is a one-day, investor & CEO summit dedicated exclusively to Cell and Gene therapy - the science, the manufacturing, and the investment driving advanced medicines forward. All happening on November 15, 2026.

(Hosted by Onyx at The Shard in London as part of London Life Sciences Week)

Speakers confirmed include:

• Steve Bates, OBE (Chair of the UK's Department of Life Sciences)
• Dr. Erik Wiklund (CEO of Circio)
• Edwin Stone (CEO of Cellular Origins)
+ many more!

Get your tickets here - for TLDR Biotech readers, use code ANIS20 at check-out for 20% off.

PMV Pharmaceuticals plans public offering of stock and warrants, precision oncology p53 therapies
Precision oncology, small molecule, p53, cancer - Read more

Rakovina Therapeutics raises $1.99M non-brokered private placement, advancing AI-powered cancer therapy pipeline
Cancer, AI/ML platform, small molecule, drug discovery, preclinical - Read more

EIT Pharma raises $35M Series A, advancing infectious disease therapies and lonafarnib FDA review
Infectious disease, small molecule, hepatitis D, clinical-stage - Read more

Holifya raises €2M ($2.32M) in funding, AI-powered digital clinic targeting obesity pharmacologic treatment
Digital health, obesity, AI-driven, metabolic syndrome, biomarker discovery - Read more

Convergen raises $15M Seed+ funding to advance targeted protein degradation platform for neurodegenerative diseases
Targeted protein degradation, neurological, Alzheimer disease, autoimmune, preclinical - Read more

Panda Therapeutics raises CHF 150K ($185.4K) from Venture Kick, advancing neurodegenerative disease treatments
Neurological, neurodegenerative, pan-amyloid platform, Alzheimer disease, preclinical - Read more

Amyl Therapeutics raises €8.25M ($9.58M) Series A extension, advancing amyloid-linked neurodegenerative disease platform
Preclinical, neurological, platform technology, immunotherapy, neurodegenerative - Read more

Adaptyv Biosystems raises $40M Series A for automated protein lab expansion
Protein design, AI/ML platform, automated lab, synthetic biology, CRO - Read more

White House strikes MFN drug pricing deals with Alcon, Astellas Pharma, BridgeBio, Teva Pharmaceuticals, and five other midsized drugmakers
Drug pricing policy, multiple disease areas, Medicaid, cost reduction - Read more

Do you offer a biotech/pharma-focused product or service?

Or looking to get investor/analyst interest on your budding start-up?

Considering sponsoring TLDR Biotech to get in-front of an engaged audience of biotech & pharma-focused professionals.

Just reply to this email* or message me on LinkedIn to learn more.

*If you’re reading this on the web version, email [email protected]

Novartis, Bristol Myers Squibb pause autoimmune CAR-T trials for rap-cel and zola-cel over safety concerns
Cell therapy, autoimmune, CAR-T, lupus, multiple sclerosis, safety concerns - Read more

Alumis' (envudeucitinib) TYK2 drug fails Ph2 study in systemic lupus erythematosus despite subgroup signals
Small molecule, autoimmune, TYK2 inhibitor, systemic lupus erythematosus, interferon gene signature - Read more

ArsenalBio pivots to in vivo CAR T, cutting majority of workforce in major strategic overhaul
In vivo CAR-T, oncology, strategic, cost reduction - Read more

FDA warns Alar Pharmaceuticals over "extremely concerning" unapproved ketamine ALA-3000 promotional claims
Small molecule, neurological, regulatory, operational - Read more

Boston Scientific halts sales of Imager II angiographic catheters after manufacturing defect causes two serious injuries
Medical device, cardiovascular, operational, safety recall - Read more

Medtronic recalls esophageal reflux monitoring capsule device linked to 184 serious injuries
Medical device, gastroenterology, operational, safety recall - Read more

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

If you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️

And lastly - connect with me on LinkedIn!

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here